Yahoo · Oct 8, 2026
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?
Sector ETF report for XPH
XP
AMEX · XPH
SPDR S&P Pharmaceuticals ETF
Financial Services · Asset Management
$61.84
Down-$1.18 (-1.87%)
Updated Oct 18, 2026, 10:36 PM
SID Score
4.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 207.79M
- P/E ratio
- —
- Dividend yield
- 0.82%
- 52-week range
- $47.60 – $74.35
- Volume
- 241.46K
- Avg. volume
- 56.55K
Price performance · XPH
XPH price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 16, 2026
XPH closed at $61.84 after 20 trading sessions, down 8.41% for the selected period.
- Last close
- $61.84
- Period change
- -8.41%
- Period low
- $61.84
- Period high
- $68.78
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | $63.29 | $63.30 | $61.60 | $61.84 | 241.46K |
| Oct 15, 2026 | $62.67 | $64.0199 | $62.67 | $63.02 | 137.72K |
| Oct 14, 2026 | $61.87 | $63.12 | $61.87 | $62.07 | 109.84K |
| Oct 13, 2026 | $64.02 | $64.02 | $62.09 | $62.10 | 75.66K |
| Oct 12, 2026 | $64.61 | $64.61 | $63.97 | $64.01 | 234.61K |
| Oct 9, 2026 | $63.64 | $65.03 | $63.54 | $64.65 | 82.54K |
| Oct 8, 2026 | $62.90 | $63.74 | $62.255 | $63.63 | 188.18K |
| Oct 7, 2026 | $62.39 | $63.66 | $62.39 | $62.91 | 252.23K |
| Oct 6, 2026 | $63.89 | $63.95 | $62.17 | $62.91 | 535.57K |
| Oct 5, 2026 | $63.56 | $64.075 | $63.03 | $63.66 | 427.16K |
| Oct 2, 2026 | $64.30 | $64.49 | $63.425 | $63.64 | 312.54K |
| Oct 1, 2026 | $64.75 | $65.32 | $63.76 | $63.78 | 589.56K |
| Sep 30, 2026 | $66.56 | $66.69 | $65.00 | $65.00 | 137.47K |
| Sep 29, 2026 | $66.68 | $66.925 | $65.89 | $66.09 | 155.11K |
| Sep 28, 2026 | $65.76 | $66.99 | $65.55 | $66.89 | 278.34K |
| Sep 25, 2026 | $66.60 | $66.685 | $65.70 | $66.09 | 65.51K |
| Sep 24, 2026 | $66.28 | $66.75 | $65.50 | $66.40 | 82.09K |
| Sep 23, 2026 | $68.81 | $68.87 | $65.9798 | $66.23 | 113.23K |
| Sep 22, 2026 | $67.99 | $68.9632 | $67.725 | $68.78 | 94.7K |
| Sep 21, 2026 | $67.28 | $67.69 | $66.685 | $67.52 | 91.81K |
Latest XPH news
The latest Smart Investors Daily articles mentioning XPH.
Stock researchCompany · Overview
Company
Market Activity
Research & News
XPH research
Overview
Company profile and research snapshot.
Company profile
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
Yahoo · Oct 6, 2026
Execution of Pharma Tariffs Brings These ETFs Into Focus
Trump's 100% pharma tariff is reshaping the drug industry. Here's how the key pharma ETFs could be affected.
Benzinga · Sep 18, 2026
'Anthropic quietly sets up biology lab as it ramps AI drug program' - Reuters Exclusive
https://www.reuters.com/world/anthropic-quietly-sets-up-biology-lab-it-ramps-ai-drug-program-2026-09-18/
SeekingAlpha · Sep 3, 2026
Trump's MFN Policy Is Reshaping Global Pharma, Not Prices
The Trump Administration this week announced nine new most-favoured nation deals with mid-sized pharma companies. Read more here.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
